Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses

• Danuta M. Skowronski ,

  * E-mail: danuta.skowronski@bccdc.ca

  Affiliations Communicable Disease Prevention and Control Service, British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada, School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
• Naveed Z. Janjua,

  Affiliations School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada, Clinical Prevention Services, British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada

  ⨯
• Gaston De Serres,

  Affiliations Department of Biological and Occupational Risks, Institut National de Santé Publique du Québec, Québec (Québec), Canada, Department of Social and Preventive Medicine, Laval University, Québec (Québec), Canada

  ⨯
• Suzana Sabaiduc,

  Affiliation Communicable Disease Prevention and Control Service, British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada

  ⨯
• Alireza Eshaghi,

  Affiliation Department of Molecular Research, Public Health Ontario, Toronto, Ontario, Canada

  ⨯
• James A. Dickinson,

  Affiliation Family Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada

  ⨯
• Kevin Fonseca,

  Affiliations Department of Virology, Provincial Laboratory of Public Health, Calgary, Alberta, Canada, Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada

  ⨯
• Anne-Luise Winter,

  Affiliation Communicable Disease Prevention and Control, Public Health Ontario, Toronto, Ontario, Canada

  ⨯
• Jonathan B. Gubbay,

  Affiliations Department of Microbiology, Public Health Ontario, Toronto, Ontario, Canada, Department of Laboratory Medicine and Pathobiology and Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada

  ⨯
• Mel Krajden,

  Affiliations Communicable Disease Prevention and Control Service, British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada, Clinical Prevention Services, British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada

  ⨯
• Martin Petric,

  Affiliations Communicable Disease Prevention and Control Service, British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada, Clinical Prevention Services, British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada

  ⨯
• Hugues Charest,

  Affiliations Laboratoire de Santé Publique du Québec, Institut National de Santé Publique du Québec, Sainte-Anne-de-Bellevue, Québec, Canada, Département De Microbiologie, Infectiologie et Immunologie, Faculté de médecine, Université de Montréal, Montréal, Québec, Canada

  ⨯
• Nathalie Bastien,

  Affiliation Influenza and Respiratory Virus Section, National Microbiology Laboratory, Winnipeg, Manitoba, Canada

  ⨯
• Trijntje L. Kwindt,

  Affiliation School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
• Salaheddin M. Mahmud,

  Affiliation Community Health Sciences and Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada

  ⨯
• Paul Van Caeseele,

  Affiliations Cadham Provincial Laboratory, Manitoba Health, Winnipeg, Manitoba, Canada, Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada

  ⨯
•  [ ... ],
• Yan Li

  Affiliations Influenza and Respiratory Virus Section, National Microbiology Laboratory, Winnipeg, Manitoba, Canada, Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada

  ⨯
• [ view all ]
• [ view less ]